Aardvark Therapeutics Faces Investor Class Action
SAN DIEGO, CA – September 10, 2026 (STL.News) Aardvark Therapeutics, Inc. (NASDAQ: AARD) is facing a federal securities class action lawsuit alleging that investors were misled about the safety and development prospects of its lead…